Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antihistamine
serotonin antagonist |
| gptkbp:approvalYear |
1961
|
| gptkbp:ATCCode |
gptkb:R06AX02
|
| gptkbp:brand |
gptkb:Periactin
|
| gptkbp:CASNumber |
gptkb:129-03-3
|
| gptkbp:contraindication |
gptkb:angle-closure_glaucoma
newborns elderly with dementia |
| gptkbp:discoveredBy |
gptkb:Merck_&_Co.
|
| gptkbp:eliminationHalfLife |
8 hours
|
| gptkbp:excretion |
urine
|
| gptkbp:hasMolecularFormula |
C21H21N
|
| https://www.w3.org/2000/01/rdf-schema#label |
cyproheptadine
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:metabolism |
hepatic
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL1413
gptkb:DB00434 4054 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
dizziness
drowsiness dry mouth increased appetite |
| gptkbp:UNII |
6R8DD6D8HV
|
| gptkbp:usedFor |
allergic rhinitis
urticaria migraine prophylaxis appetite stimulation |
| gptkbp:bfsParent |
gptkb:serotonin_syndrome
|
| gptkbp:bfsLayer |
6
|